Literature DB >> 19101991

Radiation-induced cathepsin S is involved in radioresistance.

Haeng Ran Seo1, Sangwoo Bae, Yun-Sil Lee.   

Abstract

Previous studies have suggested that the production of cathepsin S (CatS), a cysteine protease, was specifically induced in radiation-induced rat mammary tumors. In this study, we further investigate the mechanism by which CatS is induced by radiation and its function. Radiation induced production of CatS at both the mRNA and protein level, and increased its protease activity. In addition, these radiation induced changes occurred in a dose and time-dependent fashion. Agents such as bleomycin, As(2)O(3) and H(2)O(2), which produce reactive oxygen species (ROS), also induced CatS expression; however, other agents that damage DNA such as taxol and cisplatin did not. Additionally, treatment of the cells with the ROS scavengers, N-acetylcysteine and catalase, inhibited the radiation induced CatS expression. Furthermore, radiation-induced ROS was also involved in IFN-gamma production, which was responsible for radiation-mediated CatS expression. Moreover, electrophoretic mobility shift assay (EMSA) data obtained using an IFN-stimulated response element (ISRE) oligonucleotide revealed that IFN regulatory factor-1 (IRF1) was the critical transcriptional mediator of IFN-gamma-dependent CatS production after radiation. Finally, CatS overespression was found to induce radioresistance; however, knockdown of CatS resulted in the suppression of radioresistance. Taken together, the results of this study indicate that radiation induced CatS expression via ROS-IFN-gamma pathways, and that this increased expression may be involved in radioresistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19101991     DOI: 10.1002/ijc.24095

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

2.  Comparison of Proteomic Expression Profiles after Radiation Exposure across Four Different Species.

Authors:  Mary Sproull; Denise Nishita; Polly Chang; Maria Moroni; Deborah Citrin; Uma Shankavaram; Kevin Camphausen
Journal:  Radiat Res       Date:  2022-04-01       Impact factor: 3.372

Review 3.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

4.  Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents.

Authors:  Kyle C Cuneo; Jeffrey K Mito; Melodi P Javid; Jorge M Ferrer; Yongbaek Kim; W David Lee; Moungi G Bawendi; Brian E Brigman; David G Kirsch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-04       Impact factor: 7.038

Review 5.  Radiation therapy-induced metastasis: radiobiology and clinical implications.

Authors:  Benjamin J Blyth; Aidan J Cole; Michael P MacManus; Olga A Martin
Journal:  Clin Exp Metastasis       Date:  2017-11-20       Impact factor: 5.150

Review 6.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

7.  Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer.

Authors:  Song Wei; Wenwen Liu; Mingxin Xu; Huamin Qin; Chang Liu; Rui Zhang; Sihai Zhou; Encheng Li; Zhiyu Liu; Qi Wang
Journal:  Br J Cancer       Date:  2022-02-25       Impact factor: 9.075

8.  The combined effects of irradiation and herpes simplex virus type 1 infection on an immortal gingival cell line.

Authors:  Aaro Turunen; Veijo Hukkanen; Michaela Nygårdas; Jarmo Kulmala; Stina Syrjänen
Journal:  Virol J       Date:  2014-07-08       Impact factor: 4.099

9.  A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.

Authors:  Richard D A Wilkinson; Andrew Young; Roberta E Burden; Rich Williams; Christopher J Scott
Journal:  Mol Cancer       Date:  2016-04-21       Impact factor: 27.401

10.  Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation.

Authors:  SeoYoung Kim; Hee Jin; Hang-Rhan Seo; Hae June Lee; Yun-Sil Lee
Journal:  Cell Death Differ       Date:  2018-07-13       Impact factor: 15.828

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.